Top Markets
Coin of the day
Pacific Edge Limited Pacific Edge Limited

Pacific Edge Limited

PEB
Classifica tra le azioni #18663
Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001,... Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001, operates as a cancer diagnostics firm. The company's core mission involves the research, development, and commercialization of advanced diagnostic and prognostic tools aimed at the early identification and ongoing management of various cancers. Its diagnostic solutions are accessible in New Zealand, the United States, Australia, and Singapore, with operations structured across Commercial and Research segments. A key offering is the Cxbladder suite, a collection of genomic urine tests specifically designed for detecting and managing bladder cancer. Within this suite, Cxbladder Resolve aids in identifying patients likely to present with more aggressive or advanced bladder cancer. Cxbladder Triage helps pinpoint individuals with haematuria who exhibit a low probability of bladder cancer, while Cxbladder Detect offers a non-invasive method for identifying bladder and other urinary tract cancers. Furthermore, Cxbladder Monitor facilitates continuous surveillance for disease recurrence in bladder cancer patients. Beyond its focus on bladder cancer, Pacific Edge is actively developing additional diagnostic innovations. These include Cxcolorectal, a prognostic gene signature for assessing outcomes in patients diagnosed with stage II or stage III colorectal cancers, alongside pipeline products targeting gastric, endometrial cancers, and melanoma.
Prezzo delle azioni
$0.15360289
Capitalizzazione di mercato
$190.75M
Variazione (1 giorno)
6.25%
Variazione (1 anno)
94.11%
Paese
NZ
Scambia Pacific Edge Limited (PEB)

Categoria

Storico del prezzo dell'azione per Pacific Edge Limited (PEB)
Prezzo di chiusura più alto: $0.15 il 2026-08-01

Prezzo di chiusura più basso: $0.12 il 2003-10-01
Storico del prezzo dell'azione di Pacific Edge Limited dal 2003 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 37.70%
2025 36.21%
2024 24.01%
2023 -81.60%
2022 -65.88%
2021 23.95%
2020 768.10%
2019 -63.04%
2018 -7.32%
2017 -35.08%
2016 29.31%
2015 -53.04%
2014 -37.72%
2013 211.63%
2012 131.76%
2011 16.63%
2010 -14.96%
2009 177.05%
2008 -40.01%
2007 -2.18%
2006 -26.65%
2005 -29.42%
2004 82.34%
2003 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$634.40 29.87%
US
$215.88 4.67%
US
$23.08 70.53%
CN
$337.43 103.63%
US
$155.35 31.32%
US